|
|
Detection and analysis of serum bile acid spectrum in patients with cholelithiasis#br# |
JIN Suli1 WU Yan1 WANG Ran2 YANG Li1 YAN Guochao1 ZHAO Shuai1 |
1.Inspection Center, the First Hospital of Hebei Medical University, Hebei Province, Shijiazhuang 050000, China;
2.Clinical Laboratory, the Second Hospital of Hebei Medical University, Hebei Province, Shijiazhuang 050000, China |
|
|
Abstract Objective To investigate the value of serum bile acid spectrum in clinical diagnosis and early prevention of cholelithiasis by detecting the serum bile acid spectrum in patients with cholelithiasis. Methods Serum of 48 patients with gallstone (gallstone group), and 11 patients with bile duct stone (bile duct stone group) hospitalized in the First Hospital of Hebei Medical University (hereinafter referred to as “our hospital”) from September 2019 to June 2020 and 26 healthy subjects (control group) in our hospital during the same period were collected. The 15 subcomponents of bile acids (choleic acid [CA], chenodesoxycholic acid [CDCA], deoxycholic acid [DCA], lithocholic acid [LCA], glycocholic acid [GCA], glycoursodeoxycholic acid [GUDCA], glycochenodeoxycholic acid [GCDCA], glycodeoxycholic acid [GDCA], taurocholic acid [TCA], taurodeoxycholic acid [TDCA], tauroursodeoxycholic acid [TUDCA], taurochenodeoxycholic acid [TCDCA], taurolithocholic acid [TLCA], glycocholic acid [GLCA], ursodeoxycholic acid [UDCA]) were determined by high performance liquid chromatography tandem mass spectrometry and compared. Results There were statistically significant differences in six bile acid subcomponents (GCA, GUDCA, GCDCA, TCA, TUDCA, and TCDCA) among the three groups (P < 0.05). GCA, GUDCA, TCA, TCDCA, and TUDCA in gallstone group and bile duct stone group were significantly higher than those in control group, and the differences were highly statistically significant (P < 0.01). However, there were no significant differences in GCA, GUDCA, TCA, TCDCA, and TUDCA between the gallstone group and the bile duct stone group (P > 0.05). The GCDCA of gallstone group was higher than that of control group, the difference was statistically significant (P < 0.05). However, there was no significant difference in GCDCA between the bile duct stone group and the control group or between the gallstone group and bile duct stone group (P > 0.05). Conclusion The detection of serum bile acid metabolism spectrum can be an important marker for clinical diagnosis and early prevention of cholelithiasis.
|
|
|
|
|
[1] 周岚,王建祥,彭东曙.经内镜逆行性胰胆管造影术联合内镜乳头括约肌切开术治疗胆道疾病的临床效果[J].中国医药导报,2019,16(35):127-130.
[2] 中华消化杂志编辑委员会,中华医学会消化病学分会肝胆疾病协作组.中国慢性胆囊炎、胆囊结石内科诊疗共识意见(2018年)[J].中华消化杂志,2019,39(2):73-79.
[3] 吕复君,丁丹丹,刘江伟,等.新疆维吾尔自治区维吾尔族和哈萨克族及汉族女性胆囊结石的流行病学调查[J].中国全科医学,2019,22(20):2436-2440.
[4] 张三军,张付彦.腹腔镜胆囊切除术与开腹手术治疗胆结石的临床效果分析[J].现代诊断与治疗,2019,30(10):1722-1723.
[5] 杨方.腹腔镜胆囊切除术与开腹手术治疗胆结石的临床效果及对手术出血量、住院天数的影响[J].中外医学研究,2019,17(2):157-159.
[6] 周义志,姚粮.腹腔镜胆囊切除术与开腹手术治疗胆结石的效果比较[J].中国医药导报,2021,18(2):106-109.
[7] 刘剑.腹腔镜胆囊切除术对胆囊结石患者术后恢复、生活质量的影响[J].中国当代医药,2021,28(11):100-102.
[8] Zhang JW,Xiong JP,Xu WY,et al. Fruits and vegetables consumption and the risk of gallstone diasease:A systematic review and meta-analysis [J]. Medicine(Baltimore),2019,98(28):e16404.
[9] 刘昌,孟凡迪,王瑞涛.胆石症基础研究现状与展望[J].中国实用外科杂志,2021,41(1):48-51.
[10] 宋睿,杜国平.胆石症的研究进展与新认识[J].医学理论与实践,2018,31(10):1427-1428,1436.
[11] Shabanzadeh DM. Incidence of gallstone disease and complications [J]. Curr Opin Gastroenterol,2018,34(2):81-89.
[12] 李钊,班东杰.双镜联合保胆取石术对胆囊结石患者术后并发症发生率的影响观察[J].中国处方药,2021,19(7):185-186.
[13] 蔡元坤,岳正学.大肠癌与胆囊结石相关性的回顾性分析[J].实用肿瘤杂志,2002,17(1):44-45.
[14] 韩艳庆,刘媛,戚峰.胆囊结石或胆囊切除术与大肠癌关系的Meta分析[J].中国中西医结合外科杂志,2012, 18(1):17-20.
[15] Lee J,Choe S,Park JW,et al. The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea [J]. J Prev Med Public Health,2018,51(6):281-288.
[16] Zhang Y,Liu H,Li L,et al. Correction:Cholecystectomy can increase the risk of colorectal cancer:A meta-analysis of 10 cohort studies [J]. PLoS One,2018,13(1):e0191587.
[17] 刘国正.双镜联合保胆取石术与腹腔镜胆囊切除术治疗胆囊结石的效果比较[J].中国现代普通外科进展,2020, 23(4):293-295.
[18] 李衍飞,杜前程,张蒙召,等.保胆取石术适应证及术后结石复发预防措施的再认识[J].临床肝胆病杂志,2019, 35(3):690-695.
[19] 黄瑶,易剑锋,周文策.胆总管结石治疗后复发因素的研究进展[J].中国普通外科杂志,2021,30(8):964-970.
[20] 周亚柏,张开光,王成,等.ERCP治疗胆管末端良性病变并胆管炎的疗效及复发因素分析[J].安徽医科大学学报,2020,55(9):1412-1415.
[21] 王雷鸣,陈晨,丁辉,等.经内镜逆行胰胆管造影联合腹腔镜胆囊切除术后胆囊结石合并胆总管结石复发的危险因素分析[J].中华普通外科学文献(电子版),2019, 13(3):224-228.
[22] 黄鹏,魏屹,李明武.腹腔镜胆囊切除术早期治疗胆囊结石并发的急性胆源性胰腺炎的临床效果[J].中国医药导报,2020,17(23):111-114.
[23] 谷建斌,张国欣,李振符,等.微创内镜保胆取石术术后复发因素分析[J].河北医药,2014(18):2777-2779.
[24] 翁雷鸣,王秀玲.胆汁酸代谢与胆结石的关系[J].新消化病学杂志,1996,4(5):285-286.
[25] 杜文晋,邢华冰,白秀平.胆汁酸通过法尼醇受体途径调节糖代谢的研究进展[J].中国临床研究,2022,35(3):418-421.
[26] 苗彦国,薛东波,张伟辉.胆囊胆固醇结石成因及其治疗研究进展[J].肝胆胰外科杂志,2016,28(2):155-157, 177.
[27] 陈则旭.血清胆汁酸谱变化对胆结石发病预测及证候研究[D].广州:广州中医药大学,2018.
[28] 陈大义,余蓉,张丽萍,等.胆囊结石患者血清结合胆汁酸分析及临床应用[J].临床肝胆病杂志,2001,17(1):55-56.
|
|
|
|